FibroGen Competitors and Similar CompaniesClear all

FibroGen's competitors and similar companies include PhoenixBio.
FibroGen
FibroGen
FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs.
PhoenixBio
PhoenixBio
PhoenixBio (株式会社フェニックスバイオ) is a company that provides contract study services for drug discovery and development.
Founding Date
Founding Date
1993
Founding Date
2002
Type
Type
Public
Type
Public
Tags
Locations
Locations
San Francisco, US HQ
Locations
Higashihiroshima, JP HQ
New York, US
Employees
Employees
53115% increase
Employees
70
Valuation ($)
Valuation ($)
30.7 m
Valuation ($)
10.9 m

Financial

Revenue (est.)
Revenue (est.)
$6.4m (FY, 2025)
Revenue (est.)
¥1.5b (FY, 2025)
Cost of goods
Cost of goods
$556k (FY, 2025)
Cost of goods
¥405.1m (FY, 2025)
Gross profit
Gross profit
$5.9m (FY, 2025)
Gross profit
¥1.1b (FY, 2025)
Net income
Net income
$183.5m (FY, 2025)
Net income
(¥448.9m) (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

PhoenixBio
HQ
Higashihiroshima, JP
Employees
70

PhoenixBio (株式会社フェニックスバイオ) is a company that provides contract study services for drug discovery and development.

View company